Cyclerion Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cyclerion Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Cyclerion Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.38M, a 25.8% increase year-over-year.
  • Cyclerion Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$10.8M, a 495% decline year-over-year.
  • Cyclerion Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$13M, a 30.1% increase from 2022.
  • Cyclerion Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$18.5M, a 66.4% increase from 2021.
  • Cyclerion Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$55.2M, a 32.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$13M +$5.59M +30.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 -$18.5M +$36.7M +66.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$55.2M +$26.1M +32.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$81.3M +$43.8M +35% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 -$125M -$9.79M -8.49% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 -$115M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.